-
Int J Gynaecol Obstet · Aug 2006
Clinical TrialMisoprostol and active management of the third stage of labor.
- N Prata, S Hamza, R Gypson, K Nada, F Vahidnia, and M Potts.
- Bixby Program in Population, Family Planning and Maternal Health, School of Public Health, University of California, Berkeley, USA.
- Int J Gynaecol Obstet. 2006 Aug 1; 94 (2): 149-55.
ObjectiveTo compare current practices for the active management of the third stage of labor (AMTSL) with the use of 600 mug of oral misoprostol.MethodsAn operations research study was designed to compare blood loss with current AMTSL practices and misoprostol use.ResultsWomen in the misoprostol group were less likely to bleed 500 ml or more (adjusted odds ratio, 0.30; 95% confidence interval, 0.16-0.56) compared with those in the current practices group. In the current practices group 73% women required interventions because of postpartum hemorrhage, compared with 11% in the misoprostol group.ConclusionIn situations where oxytocin and or ergometrine are not consistently and appropriately used during third stage of labor, misoprostol should be considered for inclusion in the AMTSL protocol.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..